Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (251-260 of 393) with videos related to

Pageof 40
Sort By:
Health Physics|October 2, 2015
The H-ARS Dose Response Relationship (DRR): Validation and VariablesP Artur Plett, Carol H Sampson, Hui Lin Chua, et al.
Journal of Neurosurgery|December 20, 2024
Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapyManfred Westphal, Victor A Levin, Mitchel S Berger, et al.
Cancer Immunology Research|February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibodyBryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Frontiers in Immunology|February 23, 2023
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastomaSheridan L Swan, Nalini Mehta, Ekaterina Ilich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiformeChris A Learn, Tristan L Hartzell, Carol J Wikstrand, et al.
Cancer Immunology Research|November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomideDuane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1G E Archer, J H Sampson, I A Lorimer, et al.
Oncoimmunology|February 16, 2017
Systemic activation of antigen-presenting cells via RNA-loaded nanoparticlesElias J Sayour, Gabriel De Leon, Christina Pham, et al.
Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.
Neurosurgery|May 20, 2011
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working GroupMichael A Vogelbaum, Sarah Jost, Manish K Aghi, et al.
Pageof 40

Showing results (251-260 of 393) with videos related to

Sort By:
Pageof 40
Health Physics|October 2, 2015
The H-ARS Dose Response Relationship (DRR): Validation and VariablesP Artur Plett, Carol H Sampson, Hui Lin Chua, et al.
Journal of Neurosurgery|December 20, 2024
Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapyManfred Westphal, Victor A Levin, Mitchel S Berger, et al.
Cancer Immunology Research|February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibodyBryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Frontiers in Immunology|February 23, 2023
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastomaSheridan L Swan, Nalini Mehta, Ekaterina Ilich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiformeChris A Learn, Tristan L Hartzell, Carol J Wikstrand, et al.
Cancer Immunology Research|November 13, 2014
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomideDuane A Mitchell, Elias J Sayour, Elizabeth Reap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1G E Archer, J H Sampson, I A Lorimer, et al.
Oncoimmunology|February 16, 2017
Systemic activation of antigen-presenting cells via RNA-loaded nanoparticlesElias J Sayour, Gabriel De Leon, Christina Pham, et al.
Expert Review of Anticancer Therapy|May 13, 2008
Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant gliomaRichard G Everson, Michael W Graner, Matthias Gromeier, et al.
Neurosurgery|May 20, 2011
Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working GroupMichael A Vogelbaum, Sarah Jost, Manish K Aghi, et al.
Pageof 40